Catalyst Wire Dossier Catalyst Wire Dossier

Cyclosporine ophthalmic solution (2%)

cyclosporine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cyclosporine ophthalmic solution (2%), covering 2014-08-01 to 2014-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection [NA]

See pricing